HIPEC #Ovarian Cancer#Success story#Debate#Best and Economic treatment #Stage 3/4 ovarian cancer

Mouth Cancer #Best Treatment# Response and Survival#Indian Study from Bengal#cetuximab f/b Nivolumab

Relapsed ALL/Acute Lymphoblastic Leukemia /Inotuzumab Ozogomycin#CAR-T/Inovate Trial#Critical review

Adjuvant Abemaciclib/Ribociclib #monarchE/NATALEE #Best Treatment for Breast cancer #CDK 4/6 -Cure

Low dose immunotherapy #Nivolumab# cancer #is it right# The Untold story # reduce cost #Debate

salivary gland cancers#Adenoid cystic carcinoma#Androgen receptor#Novel Treatment#Abiraterone#ATRA

All you want to know about DOSTARLIMAB # 100 % cure for cancer -is it true

5 Flurouracil / capecitabine cardiotoxicity # cancer drugs and heart #Heart failure and cancer

visceral crisis, Breast cancer

IAPEN 2022 oncology guidelines

Ideal Diet for Cancer Patients

Sath Sath Session 4 (Aug 2021)

Sath Sath Session 3 (Jul 2021)

Chronic Lymphocytic Leukemia (CLL) - diagnosis, prognosis and management with Ibrutinib

Obinutuzumab - Dosage & Administration

Sath-Sath: Session2 (Jun2021)

Sequencing of Therapy in mHSPC (metastatic Hormone Sensitive Prostate Cancer) cases

Latest updates in the EGFRm NSCLC Management in 2021

Treatment of Iron Deficiency Anemia in a Cancer Patient

Sath-Sath: Session1 (May2021)

Role of Comprehensive Genomic Profiling in Cancer treatment

Management of NSCLC 2021

The Profound Trial - Lynparza in HRRm mCRPC

Impact Of Nutrition In Cancer Patients

Evolving Evidences in 1L RM SCCHN: Clinical Trials & Real World Evidences

Advances in Breast Cancer: Adjuvant Therapy Escalation and De-escalation: What is the future?

Oligometastatic Prostate Cancer

Convergence of Immunology and Oncology

Is Sequencing the right strategy for EGFRm NSCLC patients?

Afatinib Vs Erlotinib in Squamous Cell Carcinoma of Lung after failure of First line therapy